Each facility shall develop criteria to screen healthcare personnel for Mycobacterium tuberculosis (TB) based on the Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019. Each facility shall establish policies and procedures for conducting TB risk assessments that include the key components of responsibility, surveillance, and containment. The frequency of repeat screening depends upon annual facility risk results.
Tuberculin screening requirements for healthcare personnel are as follows:
(1) Each new healthcare personnel shall receive an initial individual TB risk assessment that is documented and the two-step method of tuberculin skin test or a TB blood assay test to establish a baseline within twenty-one days of employment. Any two documented tuberculin skin tests completed within twelve month period prior to the date of employment are considered two-step. A TB blood assay test completed within twelve month period prior to the date of employment or direct patient care is considered an adequate baseline test. Skin testing or TB blood assay tests are not necessary if a new healthcare personnel transfers from one licensed healthcare facility to another licensed healthcare facility within the state if the facility received documentation from the transferring healthcare facility or personnel, of the last skin or blood assay TB testing having been completed within the prior twelve months. Skin testing or TB blood assay test are not necessary if documentation is provided of a previous positive reaction to either test. Any healthcare personnel who has a newly recognized positive reaction to the skin test or TB blood assay test shall have a medical evaluation and a chest X-ray to determine the presence or absence of the active disease;(2) Each healthcare personnel who provides documentation of a positive reaction to the tuberculin skin test or TB blood assay test must have a medical evaluation and chest X-ray to determine the presence or absence of the active disease;(3) Each healthcare personnel with a history of a positive reaction to the tuberculin skin test or TB blood assay must be evaluated annually by a physician, physician assistant, nurse practitioner, clinical nurse specialist, or a nurse and a record maintained of the presence or absence of symptoms of TB. If this evaluation results in suspicion of active tuberculosis, the healthcare personnel must be referred for further medical evaluation to confirm the presence or absence of tuberculosis; and(4) Each healthcare personnel identified at increased risk for TB because of an occupational risk or current or planned immunosuppression shall receive an annual TB risk screening.S.D. Admin. R. 44:75:04:09
42 SDR 51, effective 10/13/2015; 50 SDR 062, effective 11/27/2023General Authority: SDCL 34-12-13(1)(5)(14), 34-22-9.
Law Implemented: SDCL 34-12-13(1)(5)(14).
Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019. "Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, May 17, 2019 / 68(19); pages 439-443. Copies are available at no cost at https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a3.htm.